21 research outputs found
CMR of LV non-compaction cardiomyopathy: association of clinical presentation and prognosis with cardiac phenotype
Get PDFLeft ventricular non-compaction (LVNC) is a rare congenital disorder characterized by two layered myocardium; trabeculated (non-compacted) and a non-trabeculated (compacted). LVNC is increasingly being recognized due to better imaging technology as a cause for heart failure and sudden cardiac death; however, data on clinical and imaging characteristics remains limited
Left atrial volume assessment in atrial fibrillation using multimodality imaging: a comparison of echocardiography, invasive three dimensional CARTO and cardiac magnetic resonance imaging
Get PDFComparison of two methods of right atrial volume assessment using cardiac magnetic resonance imaging: area-length method versus multislice volumetric method
Full text linkEpicardial adipose tissue volume is independently associated with aortic root size as assessed by cardiac magnetic resonance imaging
Full text linkCMR of LV non-compaction cardiomyopathy: association of clinical presentation and prognosis with cardiac phenotype
Get PDFLeft ventricular non-compaction (LVNC) is a rare congenital disorder characterized by two layered myocardium; trabeculated (non-compacted) and a non-trabeculated (compacted). LVNC is increasingly being recognized due to better imaging technology as a cause for heart failure and sudden cardiac death; however, data on clinical and imaging characteristics remains limited
Collagen Turnover Biomarkers in Atrial Fibrillation and Their Use in Clinical Management and the Study of Inflammatory Pathogenesis
No full text
Left atrial volume assessment by area-length method compared to multislice volumetric method using cardiovascular magnetic resonance imaging
Get PDFClinical utility of cardiovascular magnetic resonance in patients with cardiac rhythm management devices
No full textBiomarkers of Thrombo-Inflammatory Responses in Pulmonary Embolism Patients With Pre-Existing Versus New-Onset Atrial Fibrillation.
Get PDFPulmonary embolism (PE) patients have an increased prevalence and incidence of atrial fibrillation (AF). Because comorbid AF increases risk of morbidity and mortality, we sought to investigate the role of thrombo-inflammatory biomarkers in risk stratifying patients who experience an acute PE episode. Study participants were enrolled from a Pulmonary Embolism Response Team (PERT) registry between March 2016 and March 2019 at Loyola University Medical Center and Gottlieb Memorial Hospital. This cohort was divided into 3 groups: PE patients with a prior diagnosis of AF (n = 8), PE patients with a subsequent diagnosis of AF (n = 11), and PE patients who do not develop AF (n = 71). D-dimer, CRP, PAI-1, TAFIa, FXIIIa, A2A, MP, and TFPI were profiled using the ELISA method. All biomarkers were significantly different between controls and PE patients (P \u3c 0.05). Furthermore, TFPI was significantly elevated in PE patients who subsequently developed AF compared to PE patients who did not develop AF (157.7 ± 19.0 ng/mL vs. 129.0 ± 9.3 ng/mL, P = 0.0386). This study suggests that thrombo-inflammatory biomarkers may be helpful in indicating an acute PE episode. Also, elevated TFPI levels may be associated with an increased risk of developing AF after a PE
